Oura Ring 5 Lands 40% Smaller With Blood Pressure Signals at $399

Oura on Thursday unveiled the Oura Ring 5, a titanium band 40% smaller than its predecessor that adds nightly blood pressure trend tracking, sleep-breathing analysis, and an in-app pipe to a licensed physician. Pre-orders open today at $399, with shipping starting June 4.

Behind the design refresh sits a regulatory hinge. A January 2026 Food and Drug Administration (FDA, the U.S. agency that regulates medical devices) guidance update lets Oura release continuous blood pressure “signals” as a wellness feature, skipping the device-clearance route that Apple is reportedly walking for its next watch.

The Hardware: 40% Smaller, Twelve Signal Pathways

The form factor is where the change shows up first. Oura’s product announcement puts Ring 5 at 6.09 mm wide and 2.28 mm thick, down from 7.99 mm and 2.88 mm on the Ring 4. The company says it rebuilt the mechanical, electrical, optical, battery, and sensing architectures to hit that target, and it claims the new band reads on the finger closer to a traditional wedding ring than a wearable.

Battery life lands between six and nine days per charge, holding the roughly one-week window buyers have come to expect. An optional Charging Case sells separately for $99, extends total runtime to about a month, and supports wireless charging from the same dock.

The sensing change matters more than the millimetres. A new optical stack uses precision-engineered sensor domes, stronger LEDs, and twelve signal pathways the company says deliver cleaner readings across more finger types and skin tones. Oura claims the pulse signal is roughly 100 times stronger than wrist-worn devices, the underlying reason its ring keeps drawing recommendations for sleep and recovery work over watch-class hardware. The Ring 5 also stays IP68-rated and waterproof to 100 metres, with a scratch-resistant titanium body.

Compared head-to-head, the spec sheet looks like this:

Why January’s FDA Memo Made This Launch Possible

The reason Oura can describe nightly blood pressure patterns to consumers without filing a medical-device dossier sits in a guidance update the FDA released in January 2026. The refreshed wellness policy lets a device “estimate, infer, or output” blood pressure or blood glucose readings without clearance, provided the product is marketed for general wellness rather than diagnosis. The agency had spent years tightening the line between consumer wearables and cleared cardiac devices, and that line just moved.

Whoop and Samsung have already shipped blood pressure features under the new framework. Oura is also pursuing formal clearance for a separate blood pressure feature through a validation study scheduled to begin this year, a track the company has signalled would run longer than the consumer rollout. The Ring 5 launches as a wellness product first, with the cleared version on a longer timeline. Apple is going the harder route; its Watch Ultra 4, expected in September, is rumoured to introduce a high blood pressure notification feature that the company has submitted for agency review.

The trade-off is precision versus reach. Wellness clearance does not require formal accuracy testing under a standardised protocol. Oura is not telling users their systolic and diastolic numbers; it is showing them whether nighttime pressure is trending high, the period when a healthy cardiovascular system should naturally dip.

Health Radar’s Two Opening Acts

Oura is packaging the new cardiovascular and respiratory features under a banner called Health Radar, building on the Symptom Radar tool that launched in 2024 to flag early signs of illness. The pitch is proactive monitoring: surface a trend before a user notices the underlying problem.

Two capabilities ship on day one.

Blood Pressure Signals

Blood Pressure Signals tracks overnight cardiovascular patterns. Healthy adults usually see a dip during sleep; readings that stay elevated overnight can be an early indicator of hypertension risk, a relationship that clinical research on cuffless wearable blood pressure has examined for years. Oura surfaces those patterns inside the app and nudges members toward a clinician when the trend persists.

The feature does not deliver a single number on a cuff. It shows a longitudinal view, which is the part wearable researchers have argued was the missing piece in clinical screening. A reading taken once at a doctor’s office captures a minute. A ring worn through sleep captures roughly 56 hours per week of cardiovascular behaviour.

Nighttime Breathing

Nighttime Breathing provides a 30-day rolling view of sleep-related breathing disturbances, with guidance on when to escalate to a sleep specialist. The use case the company is signalling without naming directly is screening for sleep apnea, the condition Apple started flagging on the Watch Series 10 in late 2024 and that Samsung now offers on the Galaxy Ring.

The two features sit alongside several lower-profile additions:

• Health Records imports diagnosed conditions, prescriptions, lab results, and allergies for U.S. users into the Oura app.
• GLP-1 Insights tracks medication dosing, side effects, weight changes, and biometric response for users on drugs like Ozempic or Mounjaro.
• Lab Uploads imports blood biomarker results so they sit next to ring-derived data.
• A Brain Health Study, run through Oura Labs, pairs cognitive assessments with biometric data.
• A time-based Data Deletion tool lets users erase data from specific periods without wiping their full history.

The Counsel Health Pipe Into Billable Care

Beyond the sensors, the new software hook is a clinical partnership. Oura has linked the app to Counsel Health, an AI-driven virtual care platform, so eligible members in 43 U.S. states can route a health question through a medical chatbot and, when the situation warrants, connect to a licensed physician inside the same screen. The clinician consult costs extra on top of the standard membership.

That single hook converts Oura from a tracker into the front door of a billable healthcare interaction. Counsel Health handles the clinical liability and the prescription writing; Oura keeps the biometric context and the recurring revenue.

The financial logic is straightforward. Hardware margins on each ring get squeezed every cycle. A monthly membership that funnels users toward a physician consult creates an ongoing revenue line that does not depend on a new device launch. Whoop has been pushing the same flywheel with its membership-only model since 2020. Oura is now wired for it at scale.

Privacy questions follow that wiring. Importing diagnosed conditions, medications, and lab values into a consumer app moves the data well past what wellness wearables typically hold. Oura says U.S. users control the import and can wipe specific windows of data on demand, but the regulatory framework that governs how the merged dataset is shared with the clinical partner, and with which insurers, will take longer to settle.

Pricing, Tiers, and What Hits Doorsteps June 4

Pre-orders open today across Oura’s global storefront, with shipments starting June 4. The Ring 4 stays on the shelf for buyers who want the older ceramic body at a lower entry point.

1. $399 for the Oura Ring 5 in Silver or Black titanium.
2. $499 for Gold, Stealth, Brushed Silver, and Deep Rose finishes.
3. $349 to stay on the Ring 4 ceramic, which Oura is keeping in the lineup.
4. $99 for the optional Charging Case, which adds about a month of runtime and supports wireless charging.
5. $5.99 per month or $69.99 per year for the Oura Membership that unlocks the full health-tracking stack and Counsel Health access.

A new Locate feature helps members find a misplaced ring or case, the same trick AirTag-style trackers have been borrowing into other accessories. Live workout tracking now pulls real-time pace, distance, and heart rate when paired with a connected device, narrowing one of the gaps that pushed athletes toward dedicated sport watches.

The membership requirement still draws complaints from buyers who balk at paying for the ring and a subscription to use it. Oura’s argument has not changed: the value sits in the software stack, not the metal.

Apple and Samsung Are Coming for the 76% Moat

Oura held more than three-quarters of the global smart ring market in 2025, with one smart ring industry report from Fortune Business Insights putting the company’s share above 76%. That number is the reason every move on cardiovascular features matters: the moat is the data set, and the data set comes from being on the most fingers.

Samsung shipped roughly one million Galaxy Ring units in the first year after its 2024 launch and now holds a position inside the top-five vendor group with 9% to 10% global share, according to industry trackers. The Galaxy Ring leans on Samsung Health integration and the wider phone ecosystem, the same wedge that worked for Galaxy Watch against Garmin.

Apple is the looming variable. The Watch Ultra 4, expected in September, is reportedly getting a full redesign, eight optical sensors arranged in a ring pattern on the back, a high blood pressure notification feature in agency review, and the same proactive cardiovascular pitch shipping on Oura’s ring today. The Watch will not slip onto a finger, but it will cover the same biomarker.

Tom Hale, Oura’s chief executive, framed the launch as a step toward making the device disappear into the user’s daily life.

Oura Ring 5 is a big step toward our vision of giving every body a voice.

If the blood pressure trend feature lands as advertised and the cleared version clears the agency on schedule, Oura ends the year with a cardiovascular data set rivals cannot match on the wrist. If accuracy complaints surface in the first six months, the regulatory shortcut becomes the story, and the lead the company spent a decade building gets cut by hardware that ships in millions instead of hundreds of thousands.